Detection and avoidance of counterfeited drugs through the use of adequate active substances and ingredients;Erkennung und vermeidung von arzneimittelfälschungen durch verwendung adäquater wirk- und hilfsstoffe

Pharmazeutische Industrie

Volumn 71, Issue 12, 2009, Pages 2102-2108

  Holzgrabe, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DETERMINATION; DRUG LABELING; DRUG MANUFACTURE; DRUG PACKAGING; DRUG QUALITY; FORGERY; NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; REVIEW; X RAY DIFFRACTION;

EID: 74849088873     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Pankratz A. Raubkopien werden zum Sicherheitsrisiko. Handelsblatt. 1. 12. 2008.
2. Report on Community Customs Activities on counterfeit and Piracy. Results at the European Border. 2007. Referenz: IP/08/757.
3. http://www.mhra.gov.uk/Publications/Safetywarnings/Drugalerts
4. Stevens S. www.ukmedix.com/impotence/singapore-report-on- illegal-impotence-med-shows-4-dead- and-3-in-coma
5. Deubner R, Holzgrabe U. Micellar Electrokinetic Chromatography, High Performance Liquid Chromatography and Nuclear Magnetic resonance - Three orthogonal methods for Characterization of Critical Drugs. J Pharm Biomed Anal. 2004;35:459-467.
6. Holzgrabe U, Deubner R, Wienen F. Quality of APIs. Result of a research of di.erent gentamicin products. American Pharmaceutical Outsourcing. 2004;5:24-28.
7. EDQM. PA/PH/Exp. PCM/T (08) 2.
8. General Chapter on Inorganic Impurities: Heavy Metals. Pharmacopeial Forum. 2008;34:1345-1347.
9. Lira S, Brush P, Senak L, Wu Cs, Malawar E. Pharmacopeial Forum. 2008;34:1613-1618.
10. Polgreen L. The New York Times. 7. Februar 2009.
11. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358:2457-2467.
12. Kuehn BM. Melamine scandals highlight hazards of increasingly globalized food chain. JAMA. 2009;301:473-474.
13. Tremblay JF. Sourcing from China. C&EN. 19. Mai 2008. S. 15-20.
14. Oldenhof C. DSM, The Netherlands, President of APIC/CEFIC. Konferenz "Strategies against Counterfeit Medicines" Würzburg, 2008.
15. Holzgrabe U. Diehl B. Wawer I. NMR Spectroscopy in Pharmaceutical Analysis. Amsterdam: Elsevier; 2008.
16. 1H nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal. 2008;48:13-19.
17. 1H NMR. Pharmeuropa Bio. 2008;1:31-39.
18. Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nature Biotechn. 2008;26:669-675.
19. Sitkowski J, Bednarek E, Bocian W, Kozerski L. Assessment of Oversulfated Chondroitin Sulfate in Low Molecular Weight and Unfractionated Heparin Di.usion Ordered Nuclear Magnetic Resonance Spectroscopy Method. J Med Chem. 2008;51:7663-7665.
20. Bigler P, Brenneisen R. Improved impurity fingerprinting by high resolution 1H NMR spectroscopy. J Pharm Biomed Anal. 2009;49:1060-1064
21. Tre. S, Routaboul C, Hamieh S, Gilard V, Malet-Martino M, Martino R. Analysis of illegally manufactured formulations of tadalafil (Cialis ) by 1H NMR, 2D DOSY 1H NMR and Raman spectroscopy. J Pharm Biomed Anal. 2008;47:103-113.
22. Balayssac S, Tre. S, Gilard V, Malet-Martino M, Martino R, Delsuc MA. 2D and 3D DOSY 1H NMR, a useful tool for analysis of complex mixture. Application to herbal drugs or dietary supplements for erectile dysfunction. J Pharm Biomed Anal. 2009; im Druck.
23. Gilard V, Tre. S, Balayssac S, Delsuc MA, Gostan T, Malet-Martino M, et al. DOSY NMR in Drug Analysis. In: NMR Spectroscopy in Pharmaceutical Analysis. Holzgrabe U, Wawer I, Diehl D, Hrsg. Amsterdam: Elsevier; 2008. S. 269-289.
24. Blanco M, Villarroya I. NIR spectroscopy: a rapid-response analytical tool. TrAC. 2002;21:240-250.
25. Vredenbregt MJ, Blok-Tip L, Hoogerbrugge R, Barends DM, De Kaste D. Screening suspected Viagra® and imitations of Viagra® with near-infrared spectroscopy. J Pharm Biomed Anal. 2006;40: 840-849.
26. Norwig T, Beyer T, Brinz D, Holzgrabe U, Diller M, Manns D. Prediction of the oversulfated Chondroitin Sulfate Contamination of Unfractionated Heparin by ATR-IR Spectrometry. Pharmeuropa Sci Notes. 2009;1:17-24.
27. Ricci C, Nyadong L, Yang F, Fernandez FM, Brown CD, Newton PN, Kazarian SG. Assessment of hand-held Raman instrumentation for in situ screening for potentially counterfeit artesunate antimalarial tablets by FT-Raman spectroscopy and direct ionization mass spectrometry. Anal Chim Acta. 2008;623:178-186.
28. Ricci C, Eliasson C, Macleod NA, Newton PN, Matousek P, Kazarian SG. Characterization of genuine and fake artesunate anti-malarial tablets using Fourier transform infrared imaging and spatially offset Raman spectroscopy through blister packs. Anal Bioanal Chem. 2007;389:1525-1532.
29. Becker D. X-ray beat the counterfeiters. Manufact Chemist. Juli/ Aug. 2008. S. 21-23.
30. European Pharmacopoeia. 6. Aufl. Suppl. 6.0. Straßburg: European Directorate for Quality of Medicines; 2008.